Bronchial Mucosal Microcirculation in SARS-CoV-2 Infection: Role in Innate Humoral Defense?
作者信息
Persson Carl
机构信息
University Hospital of Lund Lund, Sweden.
出版信息
Am J Respir Crit Care Med. 2022 Jul 15;206(2):228-229. doi: 10.1164/rccm.202202-0412LE.
Abstract
摘要
相似文献
1
Bronchial Mucosal Microcirculation in SARS-CoV-2 Infection: Role in Innate Humoral Defense?新型冠状病毒感染中的支气管黏膜微循环：在固有体液防御中的作用？
Am J Respir Crit Care Med. 2022 Jul 15;206(2):228-229. doi: 10.1164/rccm.202202-0412LE.
2
Early humoral defence: Contributing to confining COVID-19 to conducting airways?早期体液防御：有助于将 COVID-19 局限在气道中？
Scand J Immunol. 2021 Jun;93(6):e13024. doi: 10.1111/sji.13024. Epub 2021 Feb 7.
3
Neglected roles of IgG Fc-binding protein secreted from airway mucin-producing cells in protecting against SARS-CoV-2 infection.气道黏液产生细胞分泌的 IgG Fc 结合蛋白在预防 SARS-CoV-2 感染中的被忽视作用。
Innate Immun. 2021 Aug;27(6):423-436. doi: 10.1177/17534259211043159. Epub 2021 Sep 15.
4
Dynamic landscape mapping of humoral immunity to SARS-CoV-2 identifies non-structural protein antibodies associated with the survival of critical COVID-19 patients.动态描绘体液免疫对 SARS-CoV-2 的反应图谱，鉴定与重症 COVID-19 患者存活相关的非结构蛋白抗体。
Signal Transduct Target Ther. 2021 Aug 17;6(1):304. doi: 10.1038/s41392-021-00718-w.
5
Evaluating Humoral Immunity against SARS-CoV-2: Validation of a Plaque-Reduction Neutralization Test and a Multilaboratory Comparison of Conventional and Surrogate Neutralization Assays.评估针对 SARS-CoV-2 的体液免疫：蚀斑减少中和试验的验证和常规及替代中和测定法的多实验室比较。
Microbiol Spectr. 2021 Dec 22;9(3):e0088621. doi: 10.1128/Spectrum.00886-21. Epub 2021 Nov 17.
6
Getting to the (germinal) center of humoral immune responses to SARS-CoV-2.深入探究体液免疫应答 SARS-CoV-2 的（生发）中心。
Cell. 2022 Mar 17;185(6):945-948. doi: 10.1016/j.cell.2022.02.018.
7
Longitudinal immune profiling reveals dominant epitopes mediating long-term humoral immunity in COVID-19-convalescent individuals.纵向免疫分析揭示了介导 COVID-19 恢复期个体长期体液免疫的优势表位。
J Allergy Clin Immunol. 2022 Apr;149(4):1225-1241. doi: 10.1016/j.jaci.2022.01.005. Epub 2022 Jan 21.
8
SARS-CoV-2-specicific humoral immunity in convalescent patients with mild COVID-19 is supported by CD4 T-cell help and negatively correlated with Alphacoronavirus-specific antibody titer.SARS-CoV-2 特异性体液免疫在轻症 COVID-19 恢复期患者中得到 CD4 T 细胞辅助的支持，与 Alphacoronavirus 特异性抗体滴度呈负相关。
Immunol Lett. 2022 Dec;251-252:38-46. doi: 10.1016/j.imlet.2022.09.007. Epub 2022 Sep 27.
9
Natural humoral immunity per year after SARS-CoV-2 infection in hospitalized patients.住院患者感染新冠病毒后每年的自然体液免疫情况。
Enferm Infecc Microbiol Clin (Engl Ed). 2022 Nov;40(9):526-527. doi: 10.1016/j.eimce.2022.04.007. Epub 2022 May 7.
10
Divergent humoral responses in mild to moderate SARS-CoV-2 infection over time - indication of persistence of the virus?轻度至中度新型冠状病毒感染中随时间变化的不同体液免疫反应——病毒持续存在的迹象？
J Infect. 2022 Mar;84(3):418-467. doi: 10.1016/j.jinf.2021.11.001. Epub 2021 Nov 6.
本文引用的文献
1
Early humoral defense under the radar: microvascular-epithelial cooperation at airways infection in asthma and health.未被察觉的早期体液防御：哮喘及健康状态下气道感染时微血管与上皮细胞的协作
Am J Physiol Lung Cell Mol Physiol. 2022 Mar 1;322(3):L503-L506. doi: 10.1152/ajplung.00470.2021.
2
The Bronchial Circulation in COVID-19 Pneumonia.新型冠状病毒肺炎中的支气管循环
Am J Respir Crit Care Med. 2022 Jan 1;205(1):121-125. doi: 10.1164/rccm.202103-0594IM.
3
'Bedside' observations challenge aspects of the 'epithelial barrier hypothesis'.“床边”观察对“上皮屏障假说”的各个方面提出了挑战。
Nat Rev Immunol. 2021 Dec;21(12):829. doi: 10.1038/s41577-021-00650-8.
4
Airways exudation of plasma macromolecules: Innate defense, epithelial regeneration, and asthma.气道渗出的血浆大分子：先天防御、上皮再生和哮喘。
J Allergy Clin Immunol. 2019 Apr;143(4):1271-1286. doi: 10.1016/j.jaci.2018.07.037. Epub 2018 Aug 29.
5
Cross-linked fibrin in the nasal fluid of patients with the common cold.普通感冒患者鼻腔分泌物中的交联纤维蛋白。
Clin Infect Dis. 2002 Mar 1;34(5):708-10. doi: 10.1086/338716. Epub 2002 Jan 25.
6
Asthma and natural colds. Inflammatory indices in induced sputum: a feasibility study.哮喘与普通感冒。诱导痰中的炎症指标：一项可行性研究。
Am J Respir Crit Care Med. 1998 Oct;158(4):1178-84. doi: 10.1164/ajrccm.158.4.9712082.
Zotero 插件